Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers.

× No keyword cloud information.

10 in total

1. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

Authors: José A Martínez; Juan P Horcajada; Manuel Almela; Francesc Marco; Alex Soriano; Elisa García; Maria Angeles Marco; Antoni Torres; Josep Mensa
Journal: Clin Infect Dis Date: 2003-01-31 Impact factor: 9.079

2. Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

Authors: M A Mufson; R J Stanek
Journal: Am J Med Date: 1999-07-26 Impact factor: 4.965

3. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals.

Authors: V Dudas; A Hopefl; R Jacobs; B J Guglielmo
Journal: Ann Pharmacother Date: 2000-04 Impact factor: 3.154

4. Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis.

Authors: S Harbarth; J Garbino; J Pugin; J A Romand; D Pittet
Journal: Eur J Clin Microbiol Infect Dis Date: 2005-10 Impact factor: 3.267

5. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Authors: E Abraham; P F Laterre; J Garbino; S Pingleton; T Butler; T Dugernier; B Margolis; K Kudsk; W Zimmerli; P Anderson; M Reynaert; D Lew; W Lesslauer; S Passe; P Cooper; A Burdeska; M Modi; A Leighton; M Salgo; P Van der Auwera
Journal: Crit Care Med Date: 2001-03 Impact factor: 7.598

6. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.

Authors: G W Waterer; G W Somes; R G Wunderink
Journal: Arch Intern Med Date: 2001 Aug 13-27

7. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

Authors: E Abraham; M P Glauser; T Butler; J Garbino; D Gelmont; P F Laterre; K Kudsk; H A Bruining; C Otto; E Tobin; C Zwingelstein; W Lesslauer; A Leighton
Journal: JAMA Date: 1997-05-21 Impact factor: 56.272

8. Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997.

Authors: P M Houck; R F MacLehose; M S Niederman; J K Lowery
Journal: Chest Date: 2001-05 Impact factor: 9.410

9. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.

Authors: Richard B Brown; Paul Iannini; Peter Gross; Mark Kunkel
Journal: Chest Date: 2003-05 Impact factor: 9.410

10. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.

Authors: Larry M Baddour; Victor L Yu; Keith P Klugman; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Carlos M Luna; David R Snydman; Wen Chien Ko; M Bernadete F Chedid; David S Hui; Antoine Andremont; Christine C C Chiou
Journal: Am J Respir Crit Care Med Date: 2004-06-07 Impact factor: 21.405

10 in total

2 in total

1. Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.

Authors: Arnab Majhi; Rana Adhikary; Aritra Bhattacharyya; Sayantika Mahanti; Biswadev Bishayi
Journal: Antimicrob Agents Chemother Date: 2014-06-23 Impact factor: 5.191

2. C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.

Authors: Donald N Ngwa; Sanjay K Singh; Alok Agrawal
Journal: Front Immunol Date: 2021-01-20 Impact factor: 8.786

2 in total